🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking penalties, legal action or prison.

Service Response and Content Removal

According to TikTok, the service has taken down violative content and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, positive reviews and detailed guides for preparing or injecting at home.

Within moments of joining one group, a vendor shared contact information, where most purchases occur. The seller sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, messages display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram said it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially significant health risks”.